I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 28% ± 8% | |
| epithelial cell | 3 studies | 23% ± 1% | |
| GABAergic neuron | 3 studies | 24% ± 2% | |
| oligodendrocyte | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 28% ± 8% | |
| epithelial cell | 3 studies | 23% ± 1% | |
| GABAergic neuron | 3 studies | 24% ± 2% | |
| oligodendrocyte | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 26% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2107.20 | 2641 / 2642 | 100% | 45.71 | 705 / 705 |
| ovary | 100% | 1782.73 | 180 / 180 | 100% | 20.45 | 428 / 430 |
| prostate | 100% | 1397.42 | 245 / 245 | 99% | 24.23 | 499 / 502 |
| esophagus | 100% | 1196.87 | 1444 / 1445 | 99% | 19.05 | 182 / 183 |
| thymus | 100% | 2204.28 | 653 / 653 | 99% | 35.34 | 601 / 605 |
| lung | 100% | 1370.52 | 576 / 578 | 100% | 22.43 | 1150 / 1155 |
| breast | 100% | 1403.73 | 459 / 459 | 99% | 23.15 | 1108 / 1118 |
| kidney | 100% | 1255.71 | 89 / 89 | 99% | 26.12 | 892 / 901 |
| uterus | 100% | 1897.04 | 170 / 170 | 98% | 19.76 | 450 / 459 |
| stomach | 100% | 1041.64 | 359 / 359 | 98% | 18.39 | 279 / 286 |
| bladder | 100% | 1438.76 | 21 / 21 | 97% | 17.27 | 491 / 504 |
| pancreas | 98% | 703.02 | 322 / 328 | 99% | 18.81 | 176 / 178 |
| intestine | 100% | 1379.34 | 966 / 966 | 97% | 17.27 | 511 / 527 |
| adrenal gland | 100% | 1704.17 | 258 / 258 | 97% | 24.05 | 223 / 230 |
| skin | 100% | 1315.47 | 1801 / 1809 | 96% | 27.53 | 454 / 472 |
| liver | 99% | 816.45 | 224 / 226 | 90% | 11.34 | 367 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.41 | 29 / 29 |
| spleen | 100% | 1631.60 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 23.06 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.71 | 1 / 1 |
| adipose | 100% | 1524.48 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1599.52 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 777.66 | 834 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 83% | 10.75 | 66 / 80 |
| peripheral blood | 80% | 885.91 | 743 / 929 | 0% | 0 | 0 / 0 |
| muscle | 77% | 351.11 | 622 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0090481 | Biological process | pyrimidine nucleotide-sugar transmembrane transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0015165 | Molecular function | pyrimidine nucleotide-sugar transmembrane transporter activity |
| GO_0015297 | Molecular function | antiporter activity |
| GO_0022857 | Molecular function | transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC35A5 |
| Protein name | Alternative protein SLC35A5 UDP-sugar transporter protein SLC35A5 (Solute carrier family 35 member A5) Solute carrier family 35 member A5 |
| Synonyms | UNQ164/PRO190 |
| Description | FUNCTION: Probable UDP-sugar:UMP transmembrane antiporter involved in UDP-alpha-D-glucuronate/UDP-GlcA, UDP-GlcNAc/UDP-N-acetyl-alpha-D-glucosamine and UDP-N-acetyl-alpha-D-galactosamine/UDP-GalNAc transport from the cytosol to the lumen of the Golgi. . FUNCTION: Probable UDP-sugar:UMP transmembrane antiporter involved in UDP-alpha-D-glucuronate/UDP-GlcA, UDP-GlcNAc/UDP-N-acetyl-alpha-D-glucosamine and UDP-N-acetyl-alpha-D-galactosamine/UDP-GalNAc transport from the cytosol to the lumen of the Golgi. . FUNCTION: Probable UDP-sugar:UMP transmembrane antiporter involved in UDP-alpha-D-glucuronate/UDP-GlcA, UDP-GlcNAc/UDP-N-acetyl-alpha-D-glucosamine and UDP-N-acetyl-alpha-D-galactosamine/UDP-GalNAc transport from the cytosol to the lumen of the Golgi. . FUNCTION: Probable UDP-sugar:UMP transmembrane antiporter involved in UDP-alpha-D-glucuronate/UDP-GlcA, UDP-GlcNAc/UDP-N-acetyl-alpha-D-glucosamine and UDP-N-acetyl-alpha-D-galactosamine/UDP-GalNAc transport from the cytosol to the lumen of the Golgi. . |
| Accessions | Q9BS91 ENST00000494706.1 C9J7U8 ENST00000468642.5 ENST00000492406.6 L0R547 ENST00000261034.6 C9JXZ8 ENST00000484995.5 H7BXF8 F8WDF8 |
